To the full analysis
Silicon Laboratories stock: growth
SLABSilicon Laboratories reported $784.76M in revenue for fiscal 2025, up 34.3% on the prior year, up 9% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
2.8%
per year from 2006 to 2025, per share 5.7%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
1.1%
per year from 2006 to 2025, per share 3.9%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 9.0% | 2.0% | 2.8% |
| Revenue per share | 15.5% | 4.6% | 5.7% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | −11.0% | −3.5% | 1.1% |
| Free cash flow per share | −5.6% | −1.0% | 3.9% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $464.6M | $31.16M | $53.51M |
| 2007 | $337.46M | $204.84M | $49.39M |
| 2008 | $415.63M | $32.94M | $107.16M |
| 2009 | $441.02M | $73.09M | $112M |
| 2010 | $493.34M | $73.24M | $104.09M |
| 2011 | $491.63M | $35.47M | $80.05M |
| 2012 | $563.29M | $63.55M | −$4.99M |
| 2013 | $580.09M | $49.82M | $109.68M |
| 2014 | $620.7M | $38.02M | $126.22M |
| 2015 | $644.83M | $29.59M | $94.18M |
| 2016 | $697.63M | $61.49M | $117.98M |
| 2017 | $768.87M | $47.09M | $177.27M |
| 2018 | $868.27M | $83.59M | $149.08M |
| 2019 | $473.79M | $19.27M | $150.24M |
| 2020 | $510.93M | $12.53M | $117.63M |
| 2021 | $720.86M | $2.12B | −$129.02M |
| 2022 | $1.02B | $91.4M | $45.28M |
| 2023 | $782.26M | −$34.52M | −$52.63M |
| 2024 | $584.39M | −$191.01M | −$25.66M |
| 2025 | $784.76M | −$64.91M | $65.79M |
Revenue by segment
How Silicon Laboratories Inc. makes its money and how that has shifted. Names are as the company reports them.
- Industrial & Commercial57%
- Home & Life43%
Figures as a table
| 2022 | 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|---|
| Industrial & Commercial | $573.73M | $496.58M | $338.53M | $444.91M | 56.7% |
| Home & Life | $450.38M | $285.68M | $245.86M | $339.85M | 43.3% |
| Total revenue | $1.02B | $782.26M | $584.39M | $784.76M | 100% |
Revenue by region
Where Silicon Laboratories Inc. generates its revenue.
- Rest of world42%
- China33%
- Taiwan17%
- United States9%
Figures as a table
| 2022 | 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|---|
| Rest of world | $407.3M | $379.59M | $262.29M | $328.59M | 41.9% |
| China | $334.82M | $219.74M | $188.17M | $257.1M | 32.8% |
| Taiwan | $105.6M | $90.38M | $77.43M | $130.55M | 16.6% |
| United States | $176.38M | $92.55M | $56.49M | $68.52M | 8.7% |
| Total revenue | $1.02B | $782.26M | $584.39M | $784.76M | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 3 Jan 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 13 Feb 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.